BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17971774)

  • 1. Cisplatin, gemcitabine, and treosulfan in relapsed stage IV cutaneous malignant melanoma patients.
    Atzpodien J; Terfloth K; Fluck M; Reitz M
    Br J Cancer; 2007 Nov; 97(10):1329-32. PubMed ID: 17971774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cisplatin, gemcitabine and treosulfan is effective in chemotherapy-pretreated relapsed stage IV uveal melanoma patients.
    Atzpodien J; Terfloth K; Fluck M; Reitz M
    Cancer Chemother Pharmacol; 2008 Sep; 62(4):685-8. PubMed ID: 18084763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age has no significant impact on overall survival and on treatment tolerability in relapsed stage IV cutaneous malignant melanoma patients receiving Cisplatin, Gemcitabine, and Treosulfan.
    Atzpodien J; Terfloth K; Fluck M; Reitz M
    Am J Clin Oncol; 2011 Feb; 34(1):2-5. PubMed ID: 20042970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I trial combining gemcitabine and treosulfan in advanced cutaneous and uveal melanoma patients.
    Corrie PG; Shaw J; Spanswick VJ; Sehmbi R; Jonson A; Mayer A; Bulusu R; Hartley JA; Cree IA
    Br J Cancer; 2005 Jun; 92(11):1997-2003. PubMed ID: 15886706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A two-cohort phase II clinical trial of gemcitabine plus treosulfan in patients with metastatic uveal melanoma.
    Schmittel A; Schuster R; Bechrakis NE; Siehl JM; Foerster MH; Thiel E; Keilholz U
    Melanoma Res; 2005 Oct; 15(5):447-51. PubMed ID: 16179873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial of cisplatin, gemcitabine and treosulfan in patients with metastatic uveal melanoma.
    Schmittel A; Scheulen ME; Bechrakis NE; Strumberg D; Baumgart J; Bornfeld N; Foerster MH; Thiel E; Keilholz U
    Melanoma Res; 2005 Jun; 15(3):205-7. PubMed ID: 15917703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical phase I trial of gemcitabine and treosulfan in uveal melanoma and other solid tumours.
    Keilholz U; Schuster R; Schmittel A; Bechrakis N; Siehl J; Foerster MH; Thiel E
    Eur J Cancer; 2004 Sep; 40(14):2047-52. PubMed ID: 15341977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treosulfan in the treatment of metastatic melanoma: from chemosensitivity testing to clinical trials.
    Neuber K
    Recent Results Cancer Res; 2003; 161():159-79. PubMed ID: 12528807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treosulfan and gemcitabine in metastatic uveal melanoma patients: results of a multicenter feasibility study.
    Pföhler C; Cree IA; Ugurel S; Kuwert C; Haass N; Neuber K; Hengge U; Corrie PG; Zutt M; Tilgen W; Reinhold U
    Anticancer Drugs; 2003 Jun; 14(5):337-40. PubMed ID: 12782938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of in vitro chemosensitivity testing: the example of uveal melanoma.
    Terheyden P; Bröcker EB; Becker JC
    J Cancer Res Clin Oncol; 2004 Jul; 130(7):395-9. PubMed ID: 15160290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bleomycin, vinorelbine and trofosfamide in relapsed stage IV cutaneous malignant melanoma patients.
    Atzpodien J; Morawek L; Fluck M; Reitz M
    Cancer Chemother Pharmacol; 2009 Oct; 64(5):901-5. PubMed ID: 19229537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second-line chemotherapy of metastatic malignant melanoma with intravenous treosulfan: a phase II multicentre trial.
    Neuber K; Reinhold U; Deutschmann A; Pföhler C; Mohr P; Pichlmeier U; Baumgart J; Hauschild A
    Melanoma Res; 2003 Feb; 13(1):81-5. PubMed ID: 12569289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gemcitabine and cisplatin treatment of advanced-stage non-small-cell lung cancer in patients given cisplatin on day 8.
    Akcali Z; Calikusu Z; Sakalli H; Ozyilkan O
    Tumori; 2008; 94(4):474-80. PubMed ID: 18822681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gemcitabine alone or combined with cisplatin in relapsed or refractory multiple myeloma.
    Offidani M; Mele A; Corvatta L; Marconi M; Malerba L; Olivieri A; Rupoli S; Alesiani F; Leoni P
    Leuk Lymphoma; 2002 Jun; 43(6):1273-9. PubMed ID: 12152996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized phase II trial of gemcitabine plus treosulfan versus treosulfan alone in patients with metastatic uveal melanoma.
    Schmittel A; Schmidt-Hieber M; Martus P; Bechrakis NE; Schuster R; Siehl JM; Foerster MH; Thiel E; Keilholz U
    Ann Oncol; 2006 Dec; 17(12):1826-9. PubMed ID: 16971664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gemcitabine, vinorelbine and cisplatin combination chemotherapy in advanced non-small cell lung cancer: a phase II trial.
    Laack E; Mende T; Dürk H; Kneba M; Dickgreber N; Welte T; Müller T; Scholtze J; Graeven U; Jasiewicz Y; Edler L; Hossfeld DK
    Eur J Cancer; 2002 Mar; 38(5):654-60. PubMed ID: 11916547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Phase II Study of Biweekly Cisplatin, Fixed-Dose-Rate Gemcitabine and Infusional 5-Fluorouracil in Patients With Metastatic Pancreatic and Biliary Cancers.
    Davis EJ; Griffith KA; Kim EJ; Ruch JM; McDonnell KJ; Zalupski MM
    Am J Clin Oncol; 2018 Feb; 41(2):128-132. PubMed ID: 26535993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro drug sensitivity predicts response and survival after individualized sensitivity-directed chemotherapy in metastatic melanoma: a multicenter phase II trial of the Dermatologic Cooperative Oncology Group.
    Ugurel S; Schadendorf D; Pföhler C; Neuber K; Thoelke A; Ulrich J; Hauschild A; Spieth K; Kaatz M; Rittgen W; Delorme S; Tilgen W; Reinhold U;
    Clin Cancer Res; 2006 Sep; 12(18):5454-63. PubMed ID: 17000680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized study comparing two different schedules of administration of cisplatin in combination with gemcitabine in advanced nonsmall cell lung carcinoma.
    Ricci S; Antonuzzo A; Galli L; Tibaldi C; Bertuccelli M; Lopes Pegna A; Petruzzelli S; Bonifazi V; Orlandini C; Franco Conte P
    Cancer; 2000 Oct; 89(8):1714-9. PubMed ID: 11042565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction chemotherapy with cisplatin and gemcitabine followed by accelerated radiotherapy and concurrent cisplatin in patients with stage IV(A-B) nasopharyngeal carcinoma.
    Yau TK; Lee AW; Wong DH; Yeung RM; Chan EW; Ng WT; Tong M; Soong IS
    Head Neck; 2006 Oct; 28(10):880-7. PubMed ID: 16721741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.